Your browser doesn't support javascript.
loading
Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area.
Shimura, Satoshi; Watari, Hideo; Komatsu, Masaru; Kuchibiro, Tomokazu; Fukuda, Saori; Nishio, Hisaaki; Kita, Machiko; Kida, Kaneyuki; Oohama, Masanobu; Toda, Hirofumi; Nishio, Motoi; Nishi, Isao; Kimura, Keigo; Sawa, Kana; Fukuda, Nozomi; Kofuku, Tomomi; Nakai, Isako; Niki, Makoto; Ono, Tamotsu; Nakamura, Tatsuya; Wada, Yasunao.
Afiliação
  • Shimura S; Department of Clinical Laboratory, Otemae Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan. Electronic address: kansenkanri@otemae.gr.jp.
  • Watari H; Department of Clinical Laboratory, Otemae Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Komatsu M; Department of Clinical Laboratory Science, Tenri Health Care University, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Kuchibiro T; Department of Clinical Laboratory, Naga Municipal Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Fukuda S; Department of Clinical Pathology, Tenri Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Nishio H; Shiga Medical Center for Children, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Kita M; Department of Clinical Laboratory, Japan Community Health Care Organization Shiga Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Kida K; Department of Clinical Laboratory, Japanese Red Cross Otsu Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Oohama M; Department of Clinical Laboratory, Japanese Red Cross Otsu Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Toda H; Department of Clinical Laboratory, Kindai University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Nishio M; Department of Clinical Laboratory, Kindai University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Nishi I; Laboratory for Clinical Investigation, Osaka University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Kimura K; Laboratory for Clinical Investigation, Osaka University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Sawa K; Department of Clinical Laboratory, Osaka Police Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Fukuda N; Department of Clinical Laboratory, Osaka Police Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Kofuku T; Department of Clinical Laboratory, Sumitomo Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Nakai I; Department of Clinical Laboratory, Sumitomo Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Niki M; Department of Central Clinical Laboratory, Osaka City University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Ono T; Department of Clinical Laboratory, Japanese Red Cross Kyoto Daini Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Nakamura T; Faculty of Health Sciences, Kyoto Tachibana University, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
  • Wada Y; Department of Clinical Laboratory, Hyogo Medical University Hospital, Japan; Study of Bacterial Resistance Kinki Region of Japan, Japan.
J Infect Chemother ; 25(11): 837-844, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31427200
ABSTRACT
Obligate anaerobes exist as resident flora in various sites in humans, but they are also emphasized as endogenous causative microorganism of infections. We performed surveillance to understand the trend of drug susceptibility in obligate anaerobic bacteria in the Kinki area of Japan. In the experiment, we used 156 obligate anaerobe isolates collected from 13 institutions that participated in the Study of Bacterial Resistance Kinki Region of Japan. MALDI Biotyper was used to identify the collected strains, and among the 156 test strains, those that could be identified with an accuracy of Score Value 2.0 or more included 6 genera, 30 species, and 144 strains (Bacteroides spp. 77 strains, Parabacteroides sp. 2 strains, Prevotella spp. 29 strains, Fusobacterium spp. 14 strains, Porphyromonas spp. 2 strains, and Clostridioides difficile 20 strains), and they were assigned as subject strains for drug susceptibility testing. The drug susceptibility test was carried out by broth microdilution method using Kyokuto Opt Panel MP ANA (Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan) and judged according to CLSI criteria. As a result, Bacteroides and Parabacteroides species showed good sensitivities to tazobactam-piperacillin, imipenem, metronidazole and chloramphenicol, and low sensitivities to ampicillin, cefoperazone and vancomycin. Prevotella species showed good sensitivities to sulbactam-ampicillin, tazobactam-piperacillin, cefmetazole, imipenem, doripenem and metronidazole. Susceptibility rates to other drugs were slightly different depending on the bacterial species. Both Fusobacterium spp. and Porphyromonas spp. showed high sensitivities to many drugs. C. difficile was highly sensitive to vancomycin and metronidazole, having MIC90s of 0.5 µg/mL and ≤2 µg/mL, respectively.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bactérias Anaeróbias / Anti-Infecciosos Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bactérias Anaeróbias / Anti-Infecciosos Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2019 Tipo de documento: Article
...